Suscribirse

Clinical outcomes of open and closed management after surgical treatments in patients with medication-related osteonecrosis of the jaw - 16/01/21

Doi : 10.1016/j.jormas.2021.01.002 
Takanori Eguchi a, , Akihiko Basugi b, Koji Kawaguchi a, Koichiro Sato a, Yoshiki Hamada a
a Department of Oral and Maxillofacial Surgery, School of Dental Medicine, Tsurumi University, 2-3-1 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan 
b Department of Oral and Maxillofacial Surgery, Toshiba Rinkan Hospital, 7-9-1 Kamitsuruma Minami-ku, Sagamihara 252-0385, Japan 

Corresponding author at: Department of Oral and Maxillofacial Surgery, School of Dental Medicine, Tsurumi University, 2-3-1 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan.Department of Oral and Maxillofacial SurgerySchool of Dental MedicineTsurumi University2-3-1 Tsurumi, Tsurumi-kuYokohama230-8501Japan
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Saturday 16 January 2021
This article has been published in an issue click here to access

Abstract

Context and purpose

To achieve success following surgical treatment of MRONJ, complete wound closure has been considered necessary; open wound management has not been generally recommended. Therefore, various closure techniques using local flaps have been reported. However, these techniques often increase surgical invasiveness, and there is minimal evidence regarding whether complete wound closure is preferable to open wound management following surgical treatment of MRONJ. The aim of this study was to clarify whether complete wound closure is necessary for successful healing following surgical treatment of MRONJ.

Procedures

This retrospective study included 52 patients with stage 2 and 3 MRONJ who underwent surgical treatment. Twenty-seven of the 52 patients received open wound management, while the remaining 25 received complete wound closure management. The outcomes of both groups were evaluated at the 6-month follow-up visit; ‘success’ was defined as complete mucosal covering without symptoms and ‘failure’ was defined as the presence of residual bone exposure or progression of disease.

Main findings

In the open wound group, 23 patients (85.1%) exhibited ‘success’ and four patients (14.8%) exhibited ‘failure’; in the closed wound group, 21 patients (84.0%) exhibited ‘success’ and four patients (16.0%) exhibited ‘failure’. These outcomes were not significantly different between groups.

Principal conclusions

Although complete wound closure has many advantages with respect to the healing process, open wound management is also acceptable for patients with difficulty achieving complete wound closure, as well as for surgeons who wish to reduce surgical invasiveness.

El texto completo de este artículo está disponible en PDF.

Abbreviations : MRONJ

Keywords : MRONJ, Stage 2 and 3, Complete wound closure, Open wound management, Surgical technique


Esquema


© 2021  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.